Analysts opine that ongoing losses overshadow higher revenue...
Analysts opine that ongoing losses overshadow higher revenue estimates for Tango Therapeutics. The narrow estimate spread indicates easy valuation or heavy reliance on key assumptions. The company's revenues are predicted to lag behind the industry.
Earnings Update: Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported And Analysts Are Boosting Their Estimates
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment